Few studies examine the effectiveness of treatments for opioid use disorder (OUD) among
Black individuals despite recent evidence suggesting opioid overdose death rates are, in …

Opioid overdose deaths have been on the rise in the United States since 1999. Naloxone is
a competitive opioid antagonist that rapidly reverses opioid overdose. The implementation of …

O presente estudo teve como finalidade evidenciar o uso indiscriminado de diclofenaco de
potássio eo desconhecimento dos efeitos colaterais deste medicamento contidos na bula …

Background: Opioid dependency is a risk factor for several negative life events and
conditions. The opioid receptor inhibitor extended-release naltrexone (XR-NTX) is safe and …

IAccording to current data published by the National System of Toxic-Pharmacological
Information (SINITOX), in 2012 drugs were responsible for 27.26% of cases of intoxication in …

Objective Buprenorphine is an essential medication for the treatment of opioid use disorder
(OUD), but studies show it has been underused over the last 2 decades. We sought to …

A pandemia de COVID-19 intensificou as reações emocionais e comportamentais, tais
como insônia, transtornos de ansiedade e depressão nos indivíduos. Consequentemente, a …

Objective: To review the chemistry, pharmacodynamics, pharmacokinetics, clinical efficacy,
tolerability, indications, and dosing and administration of methylnaltrexone methobromide …

Aim To investigate the real‐world effectiveness of pharmacological treatments
(buprenorphine, methadone) of opioid use disorder (OUD). Design A nation‐wide, register …

Aims: To determine the cost-effectiveness of pharmacy-based intranasal (IN) and
intramuscular (IM) naloxone distribution in Canada. Methods: We developed a state …